PHIO

2.48

5.53% 0.13

Handel nachbörslich: 2.53 0.05 +2.02%

Phio Pharmaceuticals Corp (PHIO)

Überblick Nachrichten Preisverlauf Financials Warum fällt PHIO? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$2.35

Offen:

$2.37

24-Stunden-Volumen:

232.42K

Relative Volume:

0.07

Marktkapitalisierung:

$12.24M

Einnahmen:

Nettoeinkommen (Verlust:

$-11.66M

KGV:

-0.3041

EPS:

-8.156

Netto-Cashflow:

$-11.09M

1W Leistung:

+12.22%

1M Leistung:

+24.00%

6M Leistung:

+37.78%

1J Leistung:

-58.98%

1-Tages-Spanne:

$2.3032

$2.53

1-Wochen-Bereich:

$2.11

$2.53

52-Wochen-Spanne:

$0.9657

$9.79

Phio Pharmaceuticals Corp Stock (PHIO) Company Profile

Firmenname

Phio Pharmaceuticals Corp

Sektor

Healthcare (1166)

Branche

Biotechnology (655)

Telefon

(508) 767-3861

Adresse

11 APEX DRIVE, SUITE 300A, MARLBOROUGH, MA

Mitarbeiter

Twitter

@phio_pharma

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

PHIO's Discussions on Twitter

Vergleichen Sie PHIO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PHIO Phio Pharmaceuticals Corp	2.48	12.24M	0	-11.66M	-11.09M	-8.156
VRTX Vertex Pharmaceuticals Inc	452.16	115.95B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	534.91	56.52B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	322.06	39.44B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	542.47	35.14B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	245.16	28.51B	3.81B	-644.79M	-669.77M	-6.24

Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-06-05	Fortgesetzt	H.C. Wainwright	Buy
2020-08-05	Eingeleitet	H.C. Wainwright	Buy

Phio Pharmaceuticals Corp Aktie (PHIO) Neueste Nachrichten

Jun 12, 2025

Phio Pharmaceuticals Announces Strategic Initiative and Leadership Changes - TipRanks

Jun 12, 2025

Phio Pharmaceuticals Appoints Lisa Carson As Principal Financial OfficerSEC Filing - marketscreener.com

Jun 12, 2025

Jun 09, 2025

Research Analysts Set Expectations for PHIO FY2025 Earnings - Defense World

Jun 09, 2025

Jun 07, 2025

What is HC Wainwright’s Forecast for PHIO Q2 Earnings? - Defense World

Jun 07, 2025

Jun 06, 2025

Phio Pharmaceuticals appoints new strategic and finance VPs By Investing.com - Investing.com South Africa

Jun 06, 2025

Phio Pharmaceuticals appoints new strategic and finance VPs - Investing.com India

Jun 06, 2025

Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio - TradingView

Jun 06, 2025

Phio Pharmaceuticals Advances 30-Drug Cancer Portfolio as Phase 1b Trial Shows Promise - Stock Titan

Jun 06, 2025

Phio Pharmaceuticals (NASDAQ:PHIO) Now Covered by HC Wainwright - Defense World

Jun 06, 2025

Jun 05, 2025

Phio Pharma (PHIO) Receives Buy Rating and $14 Price Target from HC Wainwright | PHIO Stock News - GuruFocus

Jun 05, 2025

H.C. Wainwright assumes coverage on Phio Pharma stock with Buy rating - Investing.com India

Jun 05, 2025

Phio Pharmaceuticals (PHIO) Gains 'Buy' Rating with Promising Pr - GuruFocus

Jun 05, 2025

Jun 03, 2025

2 No-Brainer Artificial Intelligence (AI) Stocks to Buy Right Now - The Globe and Mail

Jun 03, 2025

Jun 02, 2025

Phio Pharmaceuticals (NASDAQ:PHIO) Trading 2.8% Higher – Time to Buy? - Defense World

May 23, 2025

May 19, 2025

Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference - Newsfile

May 19, 2025

Phio Reveals Latest Progress on Revolutionary Cancer-Fighting siRNA Technology at Investor Conference - Stock Titan

May 19, 2025

May 15, 2025

Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - Newsfile

May 15, 2025

May 09, 2025

Metric Deep Dive: Understanding Phio Pharmaceuticals Corp (PHIO) Through its Ratios - DWinneX

May 09, 2025

May 07, 2025

Phio Pharmaceuticals Reports Positive Phase 1b Trial Results - TipRanks

May 07, 2025

Phio reports positive results in skin cancer trial - Investing.com

May 07, 2025

Phio reports positive results in skin cancer trial By Investing.com - Investing.com India

May 07, 2025

Phio Pharmaceuticals Announces Positive Pathology Results in Third Cohort in INTASYL PH-762 Skin Cancer Clinical Trial - Newsfile

May 07, 2025

May 01, 2025

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile

May 01, 2025

Phio Pharmaceuticals (PHIO) to Release Earnings on Thursday - Defense World

May 01, 2025

Apr 30, 2025

Elon Musk Could Bring Nvidia Stock $20 Billion Worth of Good News - The Globe and Mail

Apr 30, 2025

Apr 24, 2025

Best Value Stocks to Buy for April 23rd - NewsBreak: Local News & Alerts

Apr 24, 2025

Apr 23, 2025

Analysts Advise You To Maintain Your Position In Phio Pharmaceuticals Corp (NASDAQ: PHIO) - Stocksregister

Apr 23, 2025

Best Momentum Stocks to Buy for April 23rd - TradingView

Apr 23, 2025

Ratio Revelations: Shuttle Pharmaceuticals Holdings Inc (SHPH)’s Financial Metrics in the Spotlight - DWinneX

Apr 23, 2025

Financial Snapshot: Analyzing Phio Pharmaceuticals Corp (PHIO)’s Key Ratio Metrics - DWinneX

Apr 23, 2025

Apr 22, 2025

Understanding the Risks of Investing in Phio Pharmaceuticals Corp (PHIO) - knoxdaily.com

Apr 22, 2025